SNT 6.45% 3.3¢ syntara limited

Latest broker call...Credit Suisse 26/09/2011 Credit Suisse...

  1. 3,293 Posts.
    lightbulb Created with Sketch. 102
    Latest broker call...

    Credit Suisse 26/09/2011
    Credit Suisse notes the Australian Pharmaceutical Benefits Advisory Committee will meet in November and a review of the Pharmaxis submission for using Bronchitol to treat Cystic Fibrosis is expected.

    More important will be the European CHMP decision regarding the company's appeal of a negative vote for Bronchitol in Cystic Fibrosis, with the probability of this appeal difficult to predict in the broker's view. Neutral rating is retained.


    Target price is $1.11

 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
0.002(6.45%)
Mkt cap ! $42.58M
Open High Low Value Volume
3.1¢ 3.3¢ 3.1¢ $340.7K 10.37M

Buyers (Bids)

No. Vol. Price($)
3 626946 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 258862 2
View Market Depth
Last trade - 16.10pm 22/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.